Live Breaking News & Updates on Generalized Arterial Calcification

Stay updated with breaking news from Generalized arterial calcification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England's Generation Study of Rare Conditions

Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England's Generation Study of Rare Conditions
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Inozyme Pharma , Catherine Nester , Matt Pera , Stefan Riley , Corporate Communications , United Kingdom National Health Service , Exchange Commission , Inozyme Pharma Inc , Generalized Arterial Calcification , Genomic England , National Health Service , Genomics England , Generation Study , Private Securities Litigation Reform Act , Annual Report ,

Inozyme Raises $73 Million to Advance Pipeline Targeting Rare Diseases of Abnormal Mineralization

Inozyme Raises $73 Million to Advance Pipeline Targeting Rare Diseases of Abnormal Mineralization
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Inozyme Pharma , Generalized Arterial Calcification ,

The Balancing Act® on Lifetime to Feature ENPP1 Deficiency


The Balancing Act® on Lifetime to Feature ENPP1 Deficiency
Educational Episode to Highlight Symptoms of ENPP1 Deficiency and the Importance of Early Diagnosis
BOSTON, March 11, 2021 (GLOBE NEWSWIRE) Inozyme Pharma, Inc., a rare disease biopharmaceutical company developing novel therapeutics for the treatment of disorders of abnormal mineralization, announced today that ENPP1 deficiency will be featured on The Balancing Act
® as part of the show’s recurring “Behind the Mystery of Rare and Genetic Diseases” series to raise awareness for this rare, debilitating, and life-threatening mineralization disease for which there are currently no approved treatment options.
The episode will feature Janine Hicks, a patient living with ENPP1 deficiency; her parents, Donna and Peter Hicks; and Professor Zulf Mughal, a treating physician and researcher and Consultant in Pediatric Bone Disorders, Royal Manchester Children’s Hospital, Manchester University NHS Foundatio ....

United States , Peter Hicks , Inozyme Pharma , Christine Obrien , Joseph Schlessinger , Alex Van Rees , Zulf Mughal , Axel Bolte , Janine Hicks , Liz Molloy , Demetrios Braddock , Exchange Commission , Yale University , Manchester University , Inozyme Pharma Inc , Educational Episode , Highlight Symptoms , Professor Zulf Mughal , Pediatric Bone Disorders , Royal Manchester Children , Christineo Brien , Balancing Act , Generalized Arterial Calcification , Hypophosphatemic Rickets , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் ,